Danila Griffis Skaugen, is a
Speech-language Pathologist based in Whitesboro, Texas. Danila Griffis Skaugen is licensed to practice in Texas (license number 112253) and her current practice location is
1204 Sherman Dr, Whitesboro, Texas. She can be reached at her office (for appointments etc.) via phone at
(940) 564-7900.
NPI number for Danila Griffis Skaugen is 1811479652 and her current mailing address is 1600 Oak Shores Ct, Crossroads, Texas. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1811479652.
Healthcare Provider's Profile
| Full Name | Danila Griffis Skaugen |
|---|
| Gender | Female |
|---|
| Speciality | Speech-language Pathologist |
|---|
| Location | 1204 Sherman Dr, Whitesboro, Texas |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
|---|
NPI Data:
- NPI Number: 1811479652
- Provider Enumeration Date: 08/29/2018
- Last Update Date: 08/29/2018
Medical Identifiers
Medical identifiers for Danila Griffis Skaugen such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
|---|
| 1811479652 | NPI | - | NPPES |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
|---|
| 235Z00000X | Speech-language Pathologist | 112253 (Texas) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Danila Griffis Skaugen is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
|---|
Danila Griffis Skaugen,
1600 Oak Shores Ct,
Crossroads, TX 76227-8088
Ph: (940) 300-1300 | Danila Griffis Skaugen,
1204 Sherman Dr,
Whitesboro, TX 76273-9564
Ph: (940) 564-7900 |
Reviews and Comments